Director at Johnson & Johnson (NYSE: JNJ) granted deferred share units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HEWSON MARILLYN A reported acquisition or exercise transactions in this Form 4 filing.
Johnson & Johnson director Marillyn A. Hewson reported routine compensation-related awards of Deferred Share Units (DSUs), not open-market stock trades. On March 10, 2026, she received 206.4920 DSUs valued at $242.1400 each, bringing her holdings to 14512.9400 DSUs.
The filing also reflects a prior DSU award of 75.2560 units on March 4, 2025 at $166.1000 per unit. These DSUs represent deferred cash retainers under the company’s Deferred Fee Plan for Directors, are settled in cash when her board service ends, and track the fair market value of one share of common stock plus dividend equivalents.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
HEWSON MARILLYN A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Share Units | 206.492 | $242.14 | $50K |
| Grant/Award | Deferred Share Units | 75.256 | $166.10 | $13K |
Holdings After Transaction:
Deferred Share Units — 14,512.94 shares (Direct)
Footnotes (1)
- Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Acquisition of DSUs for deferral of cash retainer under the Plan.
FAQ
What did Marillyn A. Hewson report in this Johnson & Johnson (JNJ) Form 4?
Marillyn A. Hewson reported awards of Deferred Share Units (DSUs) as part of her director compensation. These are bookkeeping entries linked to her cash retainer, not open-market purchases or sales of Johnson & Johnson common stock.
Does this Johnson & Johnson Form 4 show the director buying or selling JNJ stock?
No. The filing shows grants of Deferred Share Units classified as compensation-related acquisitions. These DSUs are part of a deferred fee plan and are settled in cash, so they do not represent direct buying or selling of JNJ common stock.
When will Marillyn A. Hewson’s Johnson & Johnson DSUs be settled?
Her DSUs are scheduled to be settled in cash upon termination of her directorship. At that time, each DSU will pay the fair market value of one JNJ share on the business day before the settlement date, including prior dividend equivalents.